RubrYc nets $10 mln
RubrYc Therapeutics Inc, a biotherapeutics discovery business, has secured $10 million in funding. Third Point Ventures led the round with participation from Paladin Capital Group and Vital Venture Capital.
11 April 2018•1 min read
